Debevoise Advises Evercore as Financial Advisor to Vocera in Its Sale to Stryker For a Total Enterprise Value of Approximately $3.09 Billion

6 January 2022

Debevoise & Plimpton is advising Evercore LLC as financial advisor to Vocera Communications, Inc. (NYSE: VCRA) in its sale to Strkyer (NYSE: SYK). Under the terms of the agreement, Stryker will commence a tender offer for all outstanding shares of common stock of Vocera for $79.25 per share, or a total equity value of approximately $2.97 billion and a total enterprise value of approximately $3.09 billion (including convertible notes). For more information, please see the company’s press release.

Vocera provides clinical communication and workflow solutions that help protect and connect team members, increase operational efficiency, enhance quality of care and safety, and humanize the healthcare experience. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better.

The Debevoise team is led by M&A partners Michael Diz and William Regner and includes associate James Malmo and law clerk Keith Stackhouse.